alexa SIMULTANEOUS ESTIMATION AND VALIDATION OF EZETIMIBE AND GLIMEPRIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC | OMICS International | Abstract
ISSN: 2278-0238

International Journal of Research and Development in Pharmacy & Life Sciences
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

SIMULTANEOUS ESTIMATION AND VALIDATION OF EZETIMIBE AND GLIMEPRIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM BY RP-HPLC

Abstract

A simple, specific and accurate reverse phase high performance liquid chromatographic method was developed for the simultaneous determination Ezetimibe and Glimepride in pharmaceutical dosage form. The column used was AltimaC18 (150mm x 4.6 mm, 5m) in isocratic mode, with mobile phase containin g phosphate buffer and acetonitrile (20:80v/v). The buffer is prepared by adding 1.36gm of potassium dihyrogen ortho phosphate in a 1000ml of volumetric flask add about 900ml of milli-Q water added and degas to sonicate and finally make up the volume with water then added 1ml of triethylamine then pH adjuste d to 4.8 with dil. orthophosphoric acid solution. The flow rate was 1.0ml/ min and effluents were monitored at 228 nm. The retention times of Ezetimibe and Glimepride were found to be 2.149 min and 2.717 min, respectively. The linearity for Ezetimibe and Glimepride were in the range of 50-300 μg/ml and 5-30 μg/ml respectively. The recoveries of Ezetimibe and Glimepride were found to be 98.13 to 100.90% w/v and 98.80 to 100.45% w/v, respectively. The proposed method was validated and successfully applied to the estimation of Ezetimibe and Glimepride in combined tablet dosage forms.

Keywords

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7